chartexchange

Dixon, Kaynes and 4 Other Stocks Preferred by JPMorgan Based on Valuations

Trade Brains | Oct 23, 2026 7:29 AM EDT

The Electronics Component Manufacturing Scheme (ECMS) is an initiative launched by the Government of India on April 8, 2025, to build a self-reliant domestic electronics value chain. Designed to reduce reliance on imported sub-assemblies and raw materials such as printed circuit boards, camera modules, lithium-ion cells, and rare-earth magnets, the scheme incentivizes domestic production across components and capital goods. With an initial outlay of Rs. 22,919 crore, later increased to Rs. 40,000 crore in the Union Budget 2026–27, ECMS offers capital expenditure incentives over a five-year period within a six-year scheme tenure.

Also Read: Adani Power Q2 Results: revenue up 44.4% YoY to ₹19,438.68 Cr as net profit surges 141.5% to ₹7,019.32 Cr

As of August 2026, the scheme has approved 106 projects across 15 states, covering 30 electronic domain products with a total approved investment of Rs. 69,548 crore. Active production is already underway at 38 plants, while 16 additional projects are in advanced stages of setup. Over its lifetime, the initiative is projected to generate Rs. 5.34 lakh crore in total production, creating approximately 74,628 direct jobs and 2.5 lakh indirect jobs, supporting India's broader target of reaching a $500 billion domestic electronics manufacturing ecosystem by 2030.
JP Morgan continues to prefer electronics manufacturing services (EMS) companies that combine strong earnings growth with high return on capital employed (ROCE). The brokerage believes investors should look beyond revenue and profit growth and assess how efficiently companies use their capital to generate returns. With the EMS sector attracting attention due to rising electronics manufacturing demand, differences in valuations and capital efficiency could influence the relative attractiveness of stocks.
Valuations, Earnings Growth and ROCE
According to JP Morgan, companies offering similar earnings growth but trading at lower price-to-earnings (PE) multiples can be more attractive, particularly when they also deliver higher ROCE. A higher PE multiple may be harder to justify if a company generates lower returns on its capital despite delivering comparable earnings growth. Therefore, investors need to evaluate valuation alongside profitability and growth prospects rather than relying on earnings growth alone.
JP Morgan’s Order of Preference for EMS Stocks
JP Morgan’s order of preference places Dixon Technologies and Amber Enterprises at the top, both carrying an Overweight (OW) rating. Kaynes Technology follows with a Neutral (N) rating. The brokerage has assigned Underweight (UW) ratings to Syrma SGS Technology, Avalon Technologies and Cyient DLM. This ranking reflects the brokerage’s relative preferences among the six stocks and should not be interpreted as a guarantee of future returns.

Also Read: Jainik Power Cables secures over ₹25 Cr in rate contracts from Haryana Government for power distribution infrastructure

Reassessing EMS Stocks After Cyient DLM’s Correction
Cyient DLM’s shares dropped 17% following its Q2 FY27 earnings report on 19th of October. While total revenue grew 26.5% year-over-year to Rs. 393.1 crore and reported net profit (PAT) rose to Rs. 34 crore from Rs. 16 cr in Q1FY27, the surge in profit was primarily driven by a one-time non-recurring gain of Rs. 18.2 crore from unwinding earnout liabilities. 
The sharp decline in stock price was mainly triggered by margin contraction. EBITDA margins fell 135 basis points YoY to 8.7%. Management attributed this margin pressure to increased upfront spending on sales and marketing activities (which impacted margins by 150–200 bps) and the decision to expense product development costs immediately rather than capitalizing them. Gross and contribution margins themselves remained intact.
Despite short-term margin pressures and supply chain delays in the memory market, the company's long-term outlook remains supported by a record order backlog of Rs. 2,813 crore and a sales pipeline exceeding $1 billion. Management expects H2 FY27 revenue growth to exceed 30% and EBITDA margins to recover to 9–10% as revenues expand to absorb operating expenses.
Against this backdrop, JP Morgan is revisiting the relationship between earnings growth, price-to-earnings (PE) multiples and return on capital employed (ROCE). The brokerage continues to favour companies with strong earnings growth and high ROCE at relatively attractive valuations. For investors, the key consideration is whether a company's valuation is justified by its earnings potential, profitability and efficiency in deploying capital.

Also Read: Petronet LNG signs binding term sheet with Gruner Renewable Energy for ₹1,200 Cr compressed bio-gas joint venture

In conclusion, India’s expanding electronics manufacturing ecosystem, supported by initiatives such as ECMS, offers long-term opportunities for listed EMS companies. However, JP Morgan’s assessment highlights that industry growth alone may not determine stock performance. Investors should also evaluate earnings visibility, ROCE, and PE valuations, with Dixon Technologies and Amber Enterprises preferred by the brokerage, while Cyient DLM’s recent correction underscores the importance of monitoring profitability and execution.
 

Read original article